Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals

OBJECTIVE: To compare regimens consisting of either ritonavir-boosted atazanavir or efavirenz and a nucleoside reverse transcriptase inhibitor (NRTI) backbone with respect to clinical, immunologic, and virologic outcomes. DESIGN: Prospective studies of human immunodeficiency virus (HIV)-infected ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Cain, Lauren E., Caniglia, Ellen C., Phillips, Andrew, Olson, Ashley, Muga, Roberto, Pérez-Hoyos, Santiago, Abgrall, Sophie, Costagliola, Dominique, Rubio, Rafael, Jarrín, Inma, Bucher, Heiner, Fehr, Jan, van Sighem, Ard, Reiss, Peter, Dabis, François, Vandenhende, Marie-Anne, Logan, Roger, Robins, James, Sterne, Jonathan A. C., Justice, Amy, Tate, Janet, Touloumi, Giota, Paparizos, Vasilis, Esteve, Anna, Casabona, Jordi, Seng, Rémonie, Meyer, Laurence, Jose, Sophie, Sabin, Caroline, Hernán, Miguel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072966/
https://www.ncbi.nlm.nih.gov/pubmed/27741139
http://dx.doi.org/10.1097/MD.0000000000005133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072966/
https://www.ncbi.nlm.nih.gov/pubmed/27741139
http://dx.doi.org/10.1097/MD.0000000000005133

Ejemplares similares